🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A single dose of Reference product containing 200 mg favipiravir and a sing...
Status
Completed
Location
Novagenix Drug R&D Center
Start Date
2020-06-05
Trial ID
NCT04444986
Treatments Being Tested
A single dose of Reference product containing 200 mg favipiravir and a sing...
Status
Completed
Location
Novagenix Drug R&D Center
Start Date
2020-06-23
Trial ID
NCT04407000
Treatments Being Tested
A single dose of Reference product containing 200 mg favipiravir and a sing...
Status
Unknown
Location
Novagenix Drug R&D Center
Start Date
2020-11-13
Trial ID
NCT04651959
Treatments Being Tested
FAVIDOSE trial is a Phase I randomized, double blind controlled, monocentri...
Status
Recruiting
Location
University Hospital Bichat - Claude Bernard
Start Date
2024-05-14
Trial ID
NCT06024421
Treatments Being Tested
This is open-labe randomized multicenter comparative Phase III study conduc...
Status
Completed
Location
State Clinical Hospital №50
Start Date
2020-05-21
Trial ID
NCT04542694
Treatments Being Tested
A single dose of Reference product containing 200 mg favipiravir and a sing...
Status
Completed
Location
Novagenix Drug R&D Center
Start Date
2020-05-28
Trial ID
NCT04400682
Treatments Being Tested
This study is a randomized, double-blinded, and placebo controlled phase II...
Status
Completed
Location
Ankara City Hospital
Start Date
2020-11-16
Trial ID
NCT04981379
Treatments Being Tested
The primary objective of the study is to evaluate the efficacy and safety o...
Status
Unknown
Location
State Budgetary Healthcare Institution "City Clinical Hospital named after F.I. Inozemtsev of Moscow Healthcare Department"
Start Date
2021-07-08
Trial ID
NCT05187793
Treatments Being Tested
A single dose of Reference product containing 200 mg favipiravir and a sing...
Status
Completed
Location
Novagenix Drug R&D Center
Start Date
2020-05-14
Trial ID
NCT04406194
Treatments Being Tested